H.C. Wainwright Reiterates Buy Rating on Altimmune (ALT)

July 29, 2026 6:53 AM

H.C. Wainwright analyst Patrick Trucchio reiterated a Buy rating and $20.00 price target on Altimmune (NASDAQ: ALT).The analyst commented: "This ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found